The attorney representing Oceanside Unified School District announced on Wednesday that it was suing three drug companies and pharmacy benefit managers for collusion in hiking up insulin costs.
Some of those companies, however, are already calling the legal action baseless.
Oceanside Unified School District is one of more than 200 school districts joining in the lawsuit nationwide. The attorney representing it says they’re anticipating more districts from San Diego County to come forward.
“Our school districts, we’re going to seek all the money that they’ve overpaid,” said attorney James Frantz, the CEO of Frantz Law Group said.
The lawsuit accuses Eli Lily and Co., Novo Nordisk and Sanofi of colluding with Express Scripts, CVS Caremark and Optum Rx in inflating the price of insulin paid by the Oceanside Union District’s self-funded health plan.
The 200-page complaint alleges that pharmacy benefit managers would secure billions of dollars in rebates from drug …